Jefferies confirms its Buy recommendation on the stock, with an unchanged target of E170 ahead of the fourth-quarter release.

The analyst sees 2024 as a bottom for earnings, given the peak of destocking and the difficulties associated with exiting Russia.

'Although Q1 2025 will be lacklustre, our estimate for full-year 2025 organic sales/EBIT +3%/+4% remains unchanged' says UBS.

The current share price does not take into account this slowdown in growth and the absence of obvious short-term catalysts, which offers an attractive entry point for long-term investors", adds the research firm.

Pernod Ricard remains confident in its medium-term ambition, which targets sales growth at the top end of a range between +4 and +7%, and an expansion of the operating margin on ordinary activities by +50 to +60 basis points.

Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.